ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-DR4 Antibody [DR-4-02] (FITC) (A86110)

Mouse monoclonal [DR-4-02] antibody to DR4 (FITC) for Flow Cytometry.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 5-8 business days.
Name
Anti-DR4 Antibody [DR-4-02] (FITC)
Description
Mouse monoclonal [DR-4-02] antibody to DR4 (FITC).
Specificity
The antibody recognizes TRAIL-R1 (DR4), a human death receptor 4 (468 amino acids) expressed in most human tissues (spleen, peripheral blood leucocytes, thymus) and in a variety of tumour-derived cell lines.
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 3-5 µg/ml.
Reactivity
Human
Immunogen
Fusion protein containing the extracellular part of TRAIL-R1 and the constant part of the heavy chain of the human IgG1.
Host
Mouse
Clonality
Monoclonal
Clone ID
DR-4-02
Isotype
IgG1
Conjugate

FITC

Excitation: 490nm, Emission: 525nm

Purification
This antibody is conjugated with Fluorescein Isothiocyanate (FITC) under optimum conditions. The conjugate is purified by size-exclusion chromatography; removing unconjugated antibody and free fluorochrome.
Concentration
100 µg/ml
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline, pH 7.4, with 15 mM Sodium Azide.
Storage
Shipped at 4°C. Store in the dark at 2-8°C. Do not freeze!
Synonyms
APO2, CD261, Death receptor 4, TNF-related apoptosis-inducing ligand receptor 1, TNFRSF10A, TRAIL receptor 1, TRAIL-R1, TRAILR1, Tumor necrosis factor receptor superfamily member 10A
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-DR4 Antibody [DR-4-02] (FITC) (A86110)? Please let us know so that we can list the citation on this page.

Proteins predicted to interact with DR4

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.8% Relevancy Score
99.8% Relevancy Score
99.8% Relevancy Score
99.7% Relevancy Score
99.7% Relevancy Score
99.5% Relevancy Score
99% Relevancy Score